Kartamethasone

Each 5 ml elixir contains: Dexamethasone 0.5 mg.

Pharmaceutical form: Elixir.
Therapeutic category: Steroidal Anti inflammatory - Anti allergic .

Composition:

Each 5 ml elixir contains: Dexamethasone 0.5 mg.

 

Indications:

1- Endocrine disorders: primary or secondary, adrenocortical insufficiency cnogenital adrenal hyperplasia, nonsuppurative thyroiditis, idiopathic infantile hypercalcaemia.

2- Collagen diseases: During an exacerbation or as maintenance therapy in acute rheumatic carditis.

3- Rheumatic disorders: as adjunctive therapy for short-term administration in serious cases rheumatioid arthritis, rheumatic osteoarthritis, and adjunctive therapy for bursitis.

4- Dermatologic diseases: severe cases of pemphigus and pemphigoid, exfoliative and other cases of dermatitis, mycosis fungoides, erythema multiforme, severe psoriasis.

5- Allergic states: allergic rhinitis, bronichial asthma, contact and atopic dermatitis, hypersensitivity reactions.

6- Ophtalmic diseases: allergic conjunctivitis, keratitis, herpes zoster ophtalmicus, iritis, chorioretinitis, optic neuritis.

7- Respiratory disease: Symptomatic sarcoidosis, loeffler’s syndrome, berylliosis.

8- Hematologic diseases: idiopathic and secondary thrombocytopenic purpura, autoimmune haemolytic anemia, acute and chronic lymphocytic leukaemia, erythroblastopenia.

9- Cardiologic diseases: in some cases of pericarditis ( idiopathic, postmyocardial infraction and postcommissurotomic syndrome ).

10- Edematous states: to induce a diuresis or remission of proteinuria in the nephritic syndrome.

11- Gastrointestinal diseases: to tide that patient over a critical period of the disease in: ulcerative colitis, regional enteritis.

12- Other indications: tuberculous meningitis, trichinosis.

 

Dosage and Administration:

Usually, daily oral dosages of 0.5-10 mg are sufficient, should be take under medical supervision and must be individualized on the basis of the disease.

In some patients higher dosages may be temporarily required to control the disease. As soon as symptoms diminish, dosage should be reduced under continuous observation of the clinical picture to the lowest possible level or tapered off completely.

 
 
Home Page | About Us |  Products |  Facilities | Policies | Contact Us | Site Map